Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 16;15(1):e33849.
doi: 10.7759/cureus.33849. eCollection 2023 Jan.

Amoxicillin/Clavulanic Acid-Induced Symmetric Drug-Related Intertrigious and Flexural Exanthema

Affiliations
Case Reports

Amoxicillin/Clavulanic Acid-Induced Symmetric Drug-Related Intertrigious and Flexural Exanthema

Gulistan Alpagat et al. Cureus. .

Abstract

β-Lactams, particularly penicillins, may cause several allergic reactions. We described symmetric drug-related intertriginous and flexural exanthema (SDRIFE) illness in this case, a rare instance of systemic contact dermatitis caused by amoxicillin/clavulanic acid that needs to be considered in the differential diagnosis. A 65-year-old male patient was admitted to our Allergy Outpatient Clinic because of increased blue-purple pigmentation on the flexural surfaces of the hip, forearm, axilla, and posterior face of the neck. The patient was receiving a combination of angiotensin receptor blocker (ARB) and hydrochlorothiazide diuretic medication for hypertension. The patient used an antibiotic containing amoxicillin three months ago; As a result, there was localized redness, itching, and black spotting without any systemic symptoms. Similarly, the patient reported that when he used amoxicillin for an upper respiratory tract infection eight months ago, he experienced similar side effects within 20 days and recovered when he applied corticosteroid ointment. Due to the symmetrical site involvement following the consumption of penicillin group antibiotics with a five-month gap and subsequent comparable reactions in our patient, SDRIFE was taken into consideration. The results of the skin punch biopsy identified Baboon Syndrome (SDRIFE). Treatment with topical corticosteroids and antihistamines began. Clinically speaking, SDRIFE is distinguished by significant erythema of the gluteal/perianal area and/or V-shaped erythema of the inguinal/perigenital area, symmetric involvement of at least one other intertriginous or flexural area, and the absence of systemic signs or symptoms. The possibility that the medication may have contributed to the patient's erythematous eruption in the flexural regions should be taken into account, and the patient should be advised to stop taking the medication and not use it again.

Keywords: amoxicilline; anti-histamin; drug-induced hypersensitivity; sdrife; steroid treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Skin exanthema of various sites due to SDRIFE (A: Flexural forearm, B: Axillar area, C: Posterior neck, C: Inguinal region).
Figure 2
Figure 2. Perivascular inflammation
Figure 3
Figure 3. Parakeratozis and spongiosis

References

    1. The baboon syndrome: systemically-induced allergic contact dermatitis. Andersen KE, Hjorth N, Menné T. Contact Dermatitis. 1984;10:97–100. - PubMed
    1. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Häusermann P, Harr T, Bircher AJ. Contact Derm. 2004;51:297–310. - PubMed
    1. First report of tamoxifen-induced baboon syndrome. Mofarrah R, Mofarrah R, Kränke B, et al. J Cosmet Dermatol. 2021;20:2574–2578. - PMC - PubMed
    1. Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches. Chongpison Y, Palapinyo S, Mongkolpathumrat P, Buranapraditkun S, Thantiworasit P, Klaewsongkram J. Ann Allergy Asthma Immunol. 2022 - PubMed
    1. Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper. Romano A, Atanaskovic-Markovic M, Barbaud A, et al. Allergy. 2020;75:1300–1315. - PubMed

Publication types

LinkOut - more resources